NIH-funded research R01 grant

Understanding how heart cells control protein disposal to prevent heart failure

Official title: Cardiac Pathophysiology of Proteasome Phosphoregulation

Funded at University of South Dakota · NIH-11248064 · Data updated 2026-11-12

A research project from the University of South Dakota aims to learn how the heart’s protein disposal system works during ischemic heart disease to help prevent heart failure.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of South Dakota
NIH-funded
Lab location1 site (Vermillion, United States)
Project startSeptember 1, 2020
Project endApril 30, 2029
Funding year2026
Award (this year)$686,064
NIH project number5R01HL153614-06
Project IDNIH-11248064 on NIH RePORTER

Who could benefit from this research

Could help

Patients who have or are at risk for ischemic heart disease, heart attack, or heart failure may benefit from future therapies informed by this research.

Less likely to help

Patients without ischemic heart disease or those not connected to future proteasome-targeted therapies may not experience direct benefits.

What this research studies

This project studies how the heart’s proteasome, a protein-degrading machine, is regulated during and after a heart attack. By uncovering what goes wrong with protein disposal in heart muscle cells, researchers hope to identify new ways to keep the heart healthy after injury. The work combines molecular studies with models of heart disease to connect basic biology to potential therapies. If successful, the findings could point toward strategies that support heart recovery and delay heart failure.

Why it matters

Potential benefit: If successful, the research could reveal targets to improve heart cell cleanup after a heart attack, potentially reducing progression to heart failure.

How similar studies have gone: Previous work suggests proteasome function is linked to heart disease progression, but translating this into therapies remains an emerging area.

Where this research is happening

  • University of South Dakota
    Vermillion, United States
    Active

Researchers

  • Principal investigator: Wang, Xuejun — University of South Dakota
  • Study coordinator: Wang, Xuejun

Related research

Other NIH-funded projects on the same topics.

  • Boosting the cell cleanup system to protect against aging and Alzheimer's

    Researchers will see whether changing a tiny chemical switch on the cell's protein-cleaning machinery helps prevent aging-related damage and Alzheimer's changes in the brain and heart.

    NIH research University of South Dakota · Vermillion, United States · NIH-11297483

  • Programmable stem cells to improve survival and therapy in damaged tissues

    Researchers are developing engineered mesenchymal stem cells that can sense stress in damaged tissues and respond with protective signals to boost healing.

    NIH research University of South Dakota · Vermillion, United States · NIH-11267049

  • Mobile web app to increase cervical cancer screening for Yankton Sioux women

    A culturally tailored mobile web app will send personalized messages to help Yankton Sioux women ages 25–65 stay up to date with cervical cancer screening.

    NIH research University of South Dakota · Vermillion, United States · NIH-11170413

  • Using brain growth signals to help memory and thinking

    Testing lab-designed versions of the hormone erythropoietin that keep its brain-helping effects but not the blood effects, to help people with memory and attention problems.

    NIH research University of South Dakota · Vermillion, United States · NIH-11127435

  • South Dakota INBRE: Growing Biomedical Research in SD

    A statewide program builds biomedical research capacity in South Dakota by supporting training, collaboration, and shared core resources across universities.

    NIH research University of South Dakota · Vermillion, United States · NIH-11093670

  • Targeting HIV reservoirs in the brain to improve treatment outcomes

    This study is looking for new ways to help people with HIV by targeting hidden spots in the brain where the virus can still hide, even when they're on treatment, and it focuses on understanding how certain proteins can help in this process.

    NIH research University of South Dakota · Vermillion, United States · NIH-11081715

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.